An eventful year – CEO Linda Persson summarises 2023!

Don’t miss the opportunity to see Linda Persson summarise 2023, an eventful year in which several significant milestones were achieved.

“In summary, we have delivered as planned and strengthened our position as a company. We look forward to continuing our efforts to improve diagnostics for rectal cancer patients. Many thanks to my colleagues and to all of NanoEcho’s investors for your support and confidence. We look forward to an equally successful 2024,” says Linda Persson.

You can find out more about 2023 in the Annual Report communication that has been published today:

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.